Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3023365	li-vzvab	— (—)	569	645	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Inflammatory diseases of the central nervous system

28.14

142.09

1.3

1.1

—

Viral infections of the central nervous system, including avohilmo

23.82

119.84

1.3

1.2

—

Viral infections of the central nervous system

25.36

119.79

1.4

1.2

—

Epilepsy

121

114

10.65

111.03

1.2

1.1

—

Viral encephalitis, not elsewhere classified/unspecified, including avohilmo

57.81

95.44

1.4

1.2

—

Other encephalitis

56.69

95.24

1.4

1.1

—

Encephalitis

51.37

93.42

1.4

1.2

—

Viral encephalitis, not elsewhere classified/unspecified

56.75

93.32

1.4

1.2

—

Convulsions, not elsewhere classified

13.45

93.15

1.2

1.1

—

Focal epilepsy

9.64

76.18

1.2

1.1

—

Focal epilepsy, strict definition

9.72

71.51

1.2

1.1

—

Meningitis

25.07

69.44

1.3

1.2

—

Fever of other and unknown origin

124

176

6.12

68.03

1.2

1.1

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

9.71

67.98

1.2

1.1

—

Headache

135

178

5.87

67.85

1.1

—

Other symptoms and signs involving cognitive functions and awareness

126

200

5.60

63.86

1.2

1.1

—

Status epilepticus

30.80

63.73

1.2

1.1

—

Cerebrovascular diseases

158

255

4.31

54.38

1.2

1.1

—

Neurological diseases

120

6.56

53.85

1.1

1.0

—

Intracranial trauma

8.21

53.19

1.1

1.0

—

General symptoms and signs

173

201

4.32

52.18

1.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

178

331

3.60

47.88

1.2

1.1

—

Concussion

7.87

46.27

1.1

1.0

—

Malaise and fatigue

144

5.26

43.63

1.1

—

Bacterial infection, other or unspecified, including avohilmo

127

262

3.98

42.06

1.2

1.1

—

Bacterial infection, other or unspecified

118

240

4.16

41.77

1.2

1.1

—

Polyneuropathies and other disorders of the peripheral nervous system

102

6.51

40.74

1.2

1.1

—

Other degenerative diseases of the nervous system

10.12

40.60

1.1

1.0

—

Sequelae of cerebrovascular disease

156

4.94

39.45

1.2

1.1

—

Cerebrovascular diseases (FINNGEN)

6.04

39.20

1.1

—

Certain infectious and parasitic diseases

135

166

4.08

38.27

1.1

—

Stroke, excluding SAH

122

229

3.85

37.15

1.2

1.1

—

Stroke, including SAH

124

235

3.79

36.91

1.2

1.1

—

Implicit Sepsis

138

301

3.38

35.17

1.2

1.1

—

Implicit Sepsis, including avohilmo

144

312

3.30

35.04

1.2

1.1

—

Episodal and paroxysmal disorders

156

238

3.33

34.09

1.1

—

Abnormal findings on diagnostic imaging of central nervous system

12.48

32.42

1.3

1.2

—

Neurological diseases, wide definition

15.09

32.36

1.1

—

Speech disturbances, not elsewhere classified

8.62

32.25

1.2

1.1

—

Implicit viral Sepsis

6.07

31.80

1.2

1.1

—

Viral Sepsis

6.07

31.80

1.2

1.1

—

Ischaemic Stroke, excluding all haemorrhages

111

226

3.62

31.32

1.2

1.1

—

Implicit viral Sepsis, including avohilmo

147

4.77

31.10

1.2

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes)

141

314

3.11

31.06

1.2

1.1

—

Other and unspecified polyneuropathies, also in other diseases

5.96

30.67

1.1

—

Continuous positive airway pressure

7.30

30.48

1.3

1.1

—

Medical observation and evaluation for suspected diseases and conditions

106

133

4.08

30.44

1.1

—

STROKE

102

180

3.82

30.08

1.1

—

Other bacterial diseases

153

348

2.91

29.78

1.2

1.1

—

Bacterial Sepsis

196

3.89

29.76

1.1

—

Migraine

142

4.39

29.65

1.2

1.1

—

Other neurological diseases

129

323

3.10

29.21

1.1

—

Implicit bacterial Sepsis

182

4.01

29.03

1.1

—

Anaemias

8.76

28.67

1.2

1.0

—

Spirochaetal infections, other/unspecified

7.99

28.12

1.1

—

Visual disturbances and blindness

300

3.30

26.61

1.2

1.1

—

Delirium, not induced by alcohol and other psychoactive substances

7.25

26.59

1.2

—

Implicit bacterial Sepsis, including avohilmo

195

3.68

25.84

1.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

136

322

2.85

25.74

1.2

1.1

—

ILD medications: immunosuppressive drugs

105

308

3.09

24.74

1.2

1.1

—

Other meningitis

58.39

24.20

1.4

1.2

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

148

393

2.54

22.57

1.2

1.1

—

Pneumonia, organism unspecified

138

362

2.62

22.42

1.1

—

ILD medications: prednisolone, methylprednisolone, prednisone

153

336

2.53

21.96

1.1

—

Visual disturbances

272

3.13

21.04

1.1

—

Dizziness and giddiness

106

289

2.85

21.00

1.1

—

Influenza and pneumonia

150

380

2.44

20.56

1.1

—

Other bacterial diseases, including avohilmo

141

354

2.49

20.25

1.2

1.1

—

Organic, including symptomatic, mental disorders

215

3.05

20.06

1.2

—

ILD medications

154

344

2.41

19.92

1.1

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

141

386

2.43

19.71

1.1

—

GASTRO-related operations

143

3.23

19.40

1.1

—

Any gastric operation

143

3.23

19.40

1.1

—

Symptoms and signs involving the nervous and musculoskeletal systems

336

2.80

19.15

1.1

—

All kidney diseases

140

395

2.38

18.65

1.1

—

All pneumoniae

141

390

2.35

18.20

1.1

—

Pneumonias (Asthma/COPD co-morbidities)

140

389

2.35

18.13

1.1

—

Autoimmune diseases excluding thyroid diseases

142

324

2.38

17.87

1.1

1.2

—

Autoimmune diseases related-to ILD

123

428

2.40

17.71

1.1

1.2

—

Any death

254

2.73

17.64

1.1

1.2

—

Paralytic strabismus

7.80

17.42

1.1

1.2

—

Systemic connective tissue disorders

185

3.36

17.28

1.1

—

Zoster [herpes zoster]

4.52

17.23

1.3

1.1

—

Explicit Sepsis, including avohilmo

212

3.08

17.05

1.1

—

L04AX Other immunosuppressants

319

2.73

16.94

1.1

—

Explicit Sepsis

205

3.11

16.88

1.1

—

General examination and investigation of persons without complaint and reported diagnosis

133

3.17

16.85

1.1

—

122

291

2.45

16.79

1.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

122

291

2.45

16.79

1.1

—

Certain infectious and parasitic diseases, including avohilmo

125

3.21

16.77

1.2

1.1

—

Oral corticosteroids

144

373

2.26

16.70

1.2

1.1

—

Hydrocephalus

7.32

16.52

1.0

1.2

—

Persons encountering health services in other circumstances

234

3.01

16.47

1.2

1.1

—

Second line medication for Crohn's disease

330

2.67

16.40

1.1

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

5.94

16.35

1.2

1.1

—

Inflammatory bowel disease treatment related agents

151

379

2.21

16.33

1.2

1.1

—

Lyme disease, including avohilmo

182

3.30

16.32

1.1

—

Lyme disease

182

3.30

16.32

1.1

—

Diseases of the myoneural junction and muscle

5.18

16.24

1.2

—

Spirochaetal infections, other/unspecified, including avohilmo

183

3.29

16.18

1.1

—

Other spirochaetal diseases

183

3.29

16.18

1.1

—

Infections, IBD-co-morbidities

17.29

15.96

1.1

—

Other disorders of fluid, electrolyte and acid-base balance

159

3.38

15.85

1.2

1.1

—

Syncope and collapse

134

3.49

15.82

1.2

1.1

—

Pneumonitis due to solids and liquids

6.62

15.74

1.3

1.2

—

Symptoms and signs involving speech and voice

182

3.25

15.63

1.2

1.1

—

Exclusions for E4_PCOS_BROAD

4.52

15.58

1.2

1.1

—

Other spirochaetal diseases, including avohilmo

188

3.20

15.50

1.1

—

First line medication for Crohn's disease

141

340

2.23

15.48

1.1

—

Viral infections characterized by skin and mucous membrane lesions

242

2.90

15.25

1.3

1.1

—

Autoimmune diseases excluding thyroid diseases, strict definition

131

315

2.26

14.92

1.1

1.2

—

Renal tubulo-interstitial diseases

120

387

2.27

14.92

1.1

—

Oedema, not elsewhere classified

112

3.84

14.92

1.3

1.1

—

Septicaemia

197

3.01

14.87

1.2

1.1

—

Cerebral palsy and other paralytic syndromes

5.51

14.75

1.3

1.2

—

Other septicaemia, including avohilmo

187

3.07

14.50

1.1

—

Used for control exclusion in common control thyroid runs

129

287

2.27

14.45

1.1

—

Nausea and vomiting

133

3.53

14.38

1.2

1.1

—

Hypo-osmolality and hyponatraemia

4.26

14.08

1.1

—

Other and unspecified myopathies

5.85

13.98

1.2

—

Viral meningitis

15.92

13.94

1.5

1.3

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

107

3.79

13.70

1.1

—

Symptoms and signs involving the urinary system

106

350

2.29

13.49

1.1

—

Other diseases of urinary system

127

327

2.18

13.45

1.1

—

Other antidepressants

129

301

2.19

13.41

1.2

1.1

—

Viral meningitis, including avohilmo

13.93

13.24

1.5

1.3

—

Injuries to the head

142

411

2.05

13.09

1.1

—

Intracranial injury

331

2.42

13.07

1.1

—

Demyelinating diseases of the central nervous system

5.46

13.05

1.0

1.2

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

366

2.31

13.04

1.2

1.1

—

Other septicaemia

186

2.94

12.92

1.2

1.1

—

Other systemic involvement of connective tissue (FG)

116

3.56

12.83

1.0

1.1

—

Other headache syndromes

153

3.20

12.71

1.2

1.1

—

Guillain-Barre syndrome

32.78

12.62

1.1

1.4

—

Abnormalities of gait and mobility

4.69

12.34

1.1

1.2

—

Benzodiazepine use

129

426

2.04

12.21

1.1

—

Iron deficiency anaemia

251

2.62

12.15

1.1

—

ILD medications: azathioprine

4.75

12.10

1.2

—

Oxycodone

203

2.70

11.92

1.1

1.2

—

Other special examinations and investigations of persons without complaint or reported diagnosis

133

2.74

11.89

1.2

1.1

—

Diplopia

4.53

11.87

1.1

—

Autoimmune diseases

132

326

2.06

11.81

1.1

1.2

—

Tramadol

263

2.26

11.73

1.1

1.2

—

Acute tubulo-interstitial nephritis

326

2.28

11.50

1.2

—

Bacterial meningitis

13.74

11.46

1.2

1.1

—

Other systemic involvement of connective tissue

138

3.20

11.45

1.0

1.1

—

Other and unspecified iron deficiency

196

2.81

11.42

1.1

—

Lung diseases due to external agents

4.51

11.40

1.3

1.2

—

Other symptoms and signs involving the nervous and musculoskeletal systems

233

2.62

11.14

1.1

—

Zoster [herpes zoster], including avohilmo

307

2.36

10.91

1.3

1.1

—

Other disorders of urethra and urinary system

280

2.24

10.81

1.2

1.1

—

Complications of medical and surgical care

413

2.11

10.68

1.2

1.1

—

Depression medications

4.73

10.62

1.1

1.0

—

Dementia, including avohilmo

192

2.49

10.56

1.1

1.2

—

Migraine with aura

3.73

10.54

1.1

—

Azathioprine

4.23

10.53

1.2

—

Bleeding

108

369

2.05

10.51

1.1

1.2

—

Examination and observation for other reasons

132

2.69

10.49

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin

378

2.15

10.49

1.1

—

Nerve, nerve root and plexus disorders

131

410

1.92

10.22

1.2

1.1

—

Disorders of thyroid, IBD co-morbidities

11.42

10.21

1.1

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

114

450

1.97

10.19

1.3

1.1

—

Nutritional anaemias

287

2.33

9.89

1.1

—

Fall on same level

135

380

1.89

9.86

1.1

—

Diagnoses used for exclusion with ILD

130

3.08

9.86

1.2

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

117

377

1.96

9.85

1.2

1.1

—

Cardiovascular diseases (excluding rheumatic etc)

170

2.42

9.84

1.1

—

Strabismus

135

3.03

9.83

1.2

1.1

—

Complications of surgical and medical care, not elsewhere classified

123

428

1.92

9.83

1.1

—

Dementia

175

2.50

9.81

1.1

1.2

—

Other female pelvic inflammatory diseases

3.78

9.74

1.2

1.1

—

Presence of other devices

119

3.15

9.67

1.2

1.1

—

Other soft tissue disorders, not elsewhere classified

113

324

1.98

9.59

1.1

—

Persons encountering health services for examination and investigation

133

2.53

9.57

1.1

—

Intestinal infectious diseases

116

450

1.92

9.49

1.1

—

Dorsalgia

119

323

1.95

9.49

1.1

—

Other disorders of lacrimal gland

223

2.52

9.47

1.2

1.1

—

Pain in joint

181

2.38

9.39

1.1

1.2

—

Migraine without aura

3.86

9.38

1.1

—

Hard cardiovascular diseases

277

2.07

9.31

1.1

—

Disorders of other endocrine glands

239

2.43

9.28

1.2

1.1

—

Other reaction to severe stress, and adjustment disorders

179

2.68

9.24

1.1

—

Herpesviral [herpes simplex] infections

4.15

9.16

1.3

1.1

—

Other demyelinating diseases of the central nervous system

11.53

9.07

1.1

1.4

—

Other specific joint derangements/joint disorders

272

2.09

9.05

1.1

—

Dysphagia

133

2.94

8.89

1.2

1.1

—

Provisional assignment of new diseases of uncertain etiology

315

2.21

8.83

1.2

1.1

—

Codes for special purposes

315

2.20

8.83

1.2

1.1

—

Cardiovascular diseases

142

2.43

8.78

1.1

—

Sleep apnoea

114

379

1.90

8.77

1.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

196

2.56

8.76

1.2

1.1

—

All influenza

119

3.03

8.66

1.1

—

Nontraumatic intracranial haemmorrhage

3.46

8.61

1.0

1.1

—

Heart failure, not strict

311

2.01

8.57

1.1

—

Fitting and adjustment of other devices

188

2.49

8.56

1.1

1.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

147

2.79

8.55

1.1

—

Other external causes of accidental injury

209

2.11

8.53

1.1

—

Disturbances of skin sensation

153

2.75

8.51

1.1

—

Pain, not elsewhere classified

3.50

8.49

1.2

1.1

—

Any mental disorder

119

317

1.88

8.45

1.1

—

Disorders of lacrimal system

263

2.28

8.37

1.2

1.1

—

Complications of procedures, not elsewhere classified

415

1.92

8.36

1.1

—

Other necrotizing vasculopathies

4.89

8.36

1.1

1.2

—

Psychiatric diseases

107

276

1.94

8.35

1.2

1.1

—

Symptoms and signs involving the skin and subcutaneous tissue

421

1.97

8.27

1.2

1.1

—

Diseases of the eye and adnexa

199

2.12

8.21

1.1

—

MS-disease / Multiple Sclerosis

6.48

8.17

1.0

1.2

—

Insulin medication

307

2.08

8.17

1.2

1.1

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

119

419

1.82

8.16

1.1

—

Bell's palsy

3.91

8.14

1.1

—

Enlarged lymph nodes

4.36

8.13

1.1

—

Opioids

106

285

1.92

8.10

1.1

—

Polyarthropathies

255

2.07

8.07

1.1

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

369

2.05

8.06

1.1

—

Follow-up examination after treatment for conditions other than malignant neoplasms

107

2.74

8.03

1.0

1.1

—

COPD/asthma/ILD related infections

110

291

1.89

8.00

1.1

—

COPD/asthma related infections

110

291

1.89

8.00

1.1

—

Anxiety disorders, excluding more controls

290

1.98

7.94

1.1

—

Cellulitis

120

2.92

7.94

1.1

—

Other dorsopathies, not elsewhere classified

115

323

1.85

7.88

1.1

—

Cystitis

290

1.95

7.85

1.1

—

Low back pain

316

1.94

7.70

1.2

1.1

—

Covid-19 confirmed case

216

2.36

7.61

1.2

1.1

—

Glomerular disorders in diseases classified elsewhere

3.97

7.60

1.1

1.2

—

Visual impairment including blindness (binocular or monocular)

6.70

7.58

1.3

1.2

—

Metabolic disorders

106

344

1.85

7.54

1.2

1.1

—

Codeine

281

1.90

7.50

1.1

—

Any reimbursement code in KELA

125

2.37

7.48

1.1

—

Neurotic, stress-related and somatoform disorders

100

372

1.85

7.38

1.1

—

Cerebral cysts

7.66

7.38

1.1

1.2

—

Mood disorders, excluding more controls

100

314

1.87

7.36

1.1

—

Insulin, combination of fast acting with intermediate-acting or long-acting

352

1.98

7.35

1.2

1.1

—

Traumatic subdural haemorrhage

6.49

7.34

1.1

1.0

—

Retention of urine

160

2.43

7.30

1.1

1.2

—

COPD differential diagnosis

192

2.06

7.30

1.2

1.1

—

ILD differential diagnosis

192

2.06

7.30

1.2

1.1

—

Intestinal infectious diseases, including avohilmo, including avohilmo

129

415

1.73

7.29

1.1

—

Other necrotizing vasculopathies (FG)

6.84

7.28

1.1

1.2

—

Mycoses

143

2.66

7.28

1.2

1.1

—

Unspecified fall

305

2.09

7.26

1.2

1.1

—

Aneurysms, operations, SAH

3.49

7.25

1.0

1.1

—

Other CVD (FINNGEN)

4.40

7.19

1.1

—

Anxiety disorders

100

374

1.83

7.17

1.1

—

Visual field defects

4.49

7.17

1.1

1.2

—

Transient ischemic attack

221

2.16

7.02

1.2

1.1

—

Budesonide

3.61

7.01

1.3

1.2

—

Accidents

209

1.99

7.00

1.2

1.1

—

Parkinson's disease, excluding more controls

6.53

6.98

1.1

1.0

—

All chronic kidney diseases

259

2.06

6.96

1.1

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

268

2.15

6.94

1.2

1.1

—

Other viral diseases

158

2.53

6.92

1.2

1.1

—

Parasetamol

171

2.10

6.90

1.1

—

Leisure time condition

3.05

6.87

1.1

—

Disorders of eyelid, lacrimal system and orbit

100

408

1.80

6.82

1.2

1.1

—

Excluding asthma or asthma-COPD overlap

194

2.02

6.82

1.2

1.1

—

Exposure to other specified factors

445

1.81

6.81

1.2

1.1

—

Moderate visual impairment, binocular

11.00

6.80

1.2

1.3

—

Hypothyroidism and >3 levothyroxin purchases

3.91

6.76

1.1

1.0

—

Hypothyroidism, levothyroxine purchases

3.91

6.76

1.1

1.0

—

Special screening examination for infectious and parasitic diseases

3.33

6.75

1.2

1.1

—

Endocrine, nutritional and metabolic diseases

207

1.98

6.74

1.1

—

Disorders of choroid and retina

370

1.82

6.74

1.1

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

362

1.96

6.67

1.2

1.1

—

External causes of morbidity and mortality

162

2.10

6.65

1.1

—

Substance abuse, excluding more controls

255

2.07

6.64

1.2

1.1

—

Parkinson's disease, strict definition, excluding more controls

6.50

6.60

1.1

1.0

—

Insulin, intermediate and long-acting

331

1.98

6.59

1.2

1.1

—

Aplastic and other anaemias

265

2.07

6.50

1.1

1.2

—

Disorders of psychological development

3.98

6.42

1.3

1.1

—

Injuries to the knee and lower leg

131

427

1.66

6.37

1.2

1.1

—

Glomerular diseases

2.97

6.36

1.1

—

Subjective visual disturbances

130

2.62

6.36

1.1

—

Disorders of optic nerve and visual pathways

3.74

6.35

1.3

1.1

—

Falls/tendency to fall

110

315

1.75

6.35

1.1

1.2

—

Disorders of mineral metabolism

4.06

6.35

1.1

1.2

—

Follow-up care involving plastic surgery

8.18

6.33

1.2

1.3

—

Abnormalities of heart beat

209

2.23

6.31

1.1

—

Cerebral arteritis

+∞

6.31

1.5

0.0

—

Other and unspecified degenerative diseases of nervous system

11.10

6.30

1.1

—

Sixth [abducent] nerve palsy

9.30

6.29

1.2

1.3

—

Presence of other functional implants

243

1.97

6.28

1.1

—

Other viral diseases, including avohilmo

202

2.26

6.26

1.2

1.1

—

Antihypertensive medication - note that there are other indications

160

2.09

6.26

1.1

—

Exposure to unspecified factor

113

454

1.69

6.24

1.1

—

Other pulmonary diagnosis

194

1.96

6.23

1.2

1.1

—

Sleep apnoea, including avohilmo

112

397

1.71

6.20

1.2

1.1

—

Inflammatory diseases of female pelvic organs

230

1.99

6.20

1.2

1.1

—

Certain disorders involving the immune mechanism

2.86

6.19

1.3

1.1

—

Insulin, fast-acting

199

2.26

6.17

1.2

1.1

—

Other and unspecified anaemias

253

2.08

6.17

1.1

1.2

—

Unspecified urinary incontinence

3.97

6.16

1.2

1.1

—

L04AA Selective immunosuppressants

115

2.70

6.16

1.2

1.1

—

Pulmonary embolism

150

2.47

6.15

1.1

1.2

—

Pulmonary heart disease

150

2.47

6.15

1.1

1.2

—

Impacted cerumen

3.40

6.13

1.1

1.2

—

Type 1 diabetes

121

2.64

6.11

1.1

—

Other anaemias

254

2.06

6.06

1.1

1.2

—

Finngen Rheumatological endpoints

100

324

1.75

6.01

1.1

—

Insulin, fast-acting or short human

209

2.20

5.93

1.2

1.1

—

Other abnormal uterine and vaginal bleeding

2.71

5.92

1.2

1.1

—

Vitamin deficiency

7.26

5.92

1.1

1.2

—

Vitamin deficiency, wide

7.26

5.92

1.1

1.2

—

Senile cataract

219

1.94

5.89

1.2

—

Chronic kidney disease

183

2.26

5.87

1.1

—

Pain in limb

321

1.78

5.87

1.2

1.1

—

Other and unspecified disorders of skin and subcutaneous tissue

5.36

5.84

1.1

1.2

—

Conductive and sensorineural hearing loss

333

1.77

5.79

1.1

—

Disorders of lens

239

1.89

5.75

1.2

1.1

—

Other functional intestinal disorders

253

2.01

5.65

1.1

—

Other problems related to primary support group, including family circumstances

3.58

5.65

1.2

1.1

—

Disorders of speech understanding and production

6.75

5.65

1.4

1.2

—

Alzheimer disease, excluding more controls

4.32

5.61

1.2

1.0

—

Use of anticholinesterases

157

2.21

5.60

1.1

—

N06DA Anticholinesterases

157

2.21

5.60

1.1

—

Third [oculomotor] nerve palsy

13.00

5.59

1.1

1.4

—

Generalized anxiety disorder

3.10

5.59

1.2

1.1

—

Sensorineural hearing loss

314

1.78

5.58

1.1

1.2

—

Other mental disorders due to brain damage and dysfunction and to physical disease

3.40

5.57

1.2

—

Migraine without aura and triptan purchases

2.93

5.56

1.1

—

SLE (Finngen)

10.06

5.53

1.2

1.4

—

Hypothyroidism (congenital or acquired)

3.56

5.53

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

5.38

5.53

1.3

1.2

—

Diseases of external ear

216

2.13

5.50

1.2

1.1

—

Early onset COPD, excluding more controls

2.99

5.50

1.2

1.1

—

Other disorders of bladder

3.63

5.47

1.1

1.2

—

Factors influencing health status and contact with health services

2.84

5.45

1.2

1.1

—

Speech and linguistic disorders, excluding more controls

6.43

5.44

1.4

1.2

—

Type of accident

154

2.34

5.38

1.1

—

Caries of dentine

119

2.51

5.36

1.1

—

Pain (limb, back, neck, head abdominally)

184

1.91

5.35

1.1

—

Type 2 diabetes, wide definition

314

1.75

5.35

1.1

—

Somnolence, stupor and coma

7.90

5.34

1.4

1.1

—

Benign neoplasm of meninges

3.55

5.32

1.1

—

Iron deficiency anaemia secondary to blood loss (chronic)

2.92

5.29

1.2

1.1

—

Urinary track infection

143

2.03

5.28

1.2

1.1

—

Myalgia

125

2.48

5.26

1.1

—

Normal-pressure hydrocephalus

5.94

5.22

1.1

1.2

—

Epidural haemorrhage

+∞

5.22

1.0

0.0

—

Non-Hodgkin lymphoma, all, including Hilmo

3.13

5.18

1.1

1.2

—

Recurrent or chronic depression

118

2.29

5.17

1.1

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

306

1.89

5.16

1.1

—

Intracerebral haemorrhage

3.34

5.15

1.0

1.2

—

Missing teeth due to accident, extraction or parodontitis

360

1.79

5.12

1.3

1.1

—

Sequelae of infectious and parasitic diseases, including avohilmo

4.86

5.11

1.3

1.1

—

Hypopituitarism

4.85

5.11

1.1

1.2

—

Care involving dialysis

3.76

5.08

1.2

—

Other disorders of skin and subcutaneous tissue

396

1.73

5.08

1.1

—

Hypoglycaemia, other or unspecified

5.20

5.07

1.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

165

2.25

5.05

1.1

—

Injury, poisoning and certain other consequences of external causes

122

2.10

5.04

1.1

1.2

—

Polycystic ovarian syndrome, consortium definition

222

1.84

5.04

1.2

1.1

—

Liquid cancers

162

2.22

5.01

1.2

1.1

—

Arthropathies

280

1.70

5.00

1.1

—

Other arthritis (FG)

166

2.23

4.98

1.1

1.2

—

Diabetes mellitus

106

376

1.63

4.98

1.1

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

2.96

4.97

1.1

—

Type 1 diabetes, wide definition, subgroup 1

2.63

4.96

1.2

1.1

—

Herpesviral [herpes simplex] infections, including avohilmo

129

2.41

4.95

1.3

1.1

—

Cervicalgia

111

2.53

4.94

1.1

—

Acute upper respiratory infections of multiple and unspecified sites

359

1.71

4.94

1.1

—

Other disorders of glucose regulation and pancreatic internal secretion

4.34

4.93

1.2

—

Renal failure

261

1.89

4.92

1.1

—

Other medical care

251

1.91

4.92

1.1

—

Hypothyroidism, drug reimbursement

4.99

4.92

1.2

1.0

—

Selective serotonin reuptake inhibitors

302

1.67

4.91

1.2

1.1

—

Other specified/unspecified arthritis

142

2.33

4.90

1.1

1.2

—

Diabetes medication

107

387

1.61

4.89

1.1

—

Secondary hypertension

4.94

4.86

1.1

—

Other disorders of eye and adnexa

2.92

4.86

1.2

1.1

—

Alcohol withdrawal state with delirium

4.56

4.86

1.3

1.2

—

Symptoms and signs involving the digestive system and abdomen

299

1.66

4.86

1.2

1.1

—

Chorioretinal inflammation

7.75

4.85

1.0

1.2

—

Chronic laryngitis and laryngotracheitis

2.99

4.82

1.3

1.1

—

Diabetes, varying definitions

105

377

1.61

4.80

1.1

—

Brain glioblastoma and astrocytoma

9.10

4.79

1.2

1.4

—

Malignant neoplasm of eye, brain and central nervous system

6.50

4.77

1.2

1.4

—

Abnormal findings on diagnostic imaging of lung

282

1.88

4.76

1.2

1.1

—

Pulmonary heart disease, diseases of pulmonary circulation

176

2.16

4.75

1.2

—

Specific development disorders of speech and language

5.24

4.75

1.4

1.2

—

Gastrointestinal diseases

153

1.93

4.74

1.2

1.1

—

Heartburn

3.41

4.74

1.3

1.1

—

Cervical disc disorders

203

2.07

4.72

1.1

1.2

—

Reimbursement for rheumatic diseases

341

1.81

4.69

1.1

—

Sequelae of infectious and parasitic diseases

4.68

4.67

1.3

1.1

—

Giant cell arteritis with polymyalgia rheumatica

7.19

4.65

1.2

1.3

—

Depression or dysthymia

177

1.88

4.65

1.1

—

Infections of the skin and subcutaneous tissue

375

1.76

4.62

1.1

—

Diabetic retinopathy, strict definition

2.62

4.62

1.1

—

Diabetic maculopathy, excluding more controls

3.34

4.60

1.1

—

Other retinal disorders

309

1.75

4.58

1.1

—

Open wound of wrist and hand

265

1.90

4.56

1.1

—

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

4.53

4.55

1.1

1.2

—

Mood [affective] disorders

105

425

1.58

4.54

1.1

—

Type 1 diabetes, wide definition

104

2.50

4.52

1.2

1.1

—

Persons encountering health services in other circumstances, wide

114

374

1.57

4.51

1.1

—

Mood disorders

105

425

1.58

4.50

1.1

—

Problems related to lifestyle

3.16

4.48

1.4

1.1

—

Systemic lupus erythematosus

6.70

4.47

1.2

1.3

—

Malignant neoplasm of brain

6.70

4.47

1.2

1.3

—

Diseases of the musculoskeletal system and connective tissue

132

1.98

4.46

1.1

1.2

—

Hypothyroidism, strict autoimmune

248

1.77

4.44

1.1

—

Unspecific neurodegenerative disorder

181

1.93

4.42

1.1

1.2

—

Sleep disorders (combined)

111

370

1.57

4.42

1.1

—

Hypothyroidism, other/unspecified

353

1.64

4.41

1.1

—

Other diseases of intestines

106

375

1.57

4.38

1.1

—

Alcohol use disorder, Swedish definition

318

1.77

4.37

1.2

1.1

—

Injuries to the shoulder and upper arm

443

1.60

4.35

1.1

—

Primary_lymphoid and hematopoietic malignant neoplasms

131

2.29

4.34

1.1

1.2

—

Other heart diseases

141

2.03

4.33

1.1

—

Seronegative rheumatoid arthritis

3.34

4.32

1.1

1.2

—

DVT of lower extremities and pulmonary embolism

244

1.92

4.31

1.1

—

Genitourinary diseases

141

1.92

4.30

1.1

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

271

1.87

4.30

1.2

1.1

—

Type 2 diabetes

100

365

1.59

4.30

1.1

—

Persons encountering health services for specific procedures and health care

107

405

1.56

4.30

1.1

—

Temporal arteritis

6.29

4.29

1.2

1.3

—

Any dementia, excluding more controls

141

2.05

4.28

1.2

1.1

—

Other symptoms and signs involving general sensations and perceptions

8.92

4.28

1.0

1.3

—

Other viral diseases, not elsewhere classified

2.58

4.26

1.2

1.1

—

Suicide or other Intentional self-harm

126

2.30

4.25

1.1

—

Other nutritional deficiencies

377

1.70

4.24

1.2

1.1

—

Codeine or tramadol medication

115

407

1.53

4.24

1.1

—

329

1.74

4.21

1.2

1.1

—

Depression

411

1.58

4.21

1.1

1.2

—

Dental caries

131

2.23

4.19

1.1

—

Injuries to the ankle and foot

385

1.66

4.19

1.2

1.1

—

Speech and linguistic disorders

4.46

4.19

1.4

1.2

—

Sequelae of other and unspecified infectious and parasitic diseases, including avohilmo

4.82

4.18

1.3

1.1

—

Explicit bacterial Sepsis, including avohilmo

3.42

4.18

1.1

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

6.97

4.16

1.2

1.3

—

Chronic lymphocytic leukaemia, helper endpoint

6.97

4.16

1.2

1.3

—

Chronic lymphocytic leukaemia

6.97

4.16

1.2

1.3

—

Rheumatoid arthritis, including avohilmo

207

1.98

4.14

1.1

—

Symptoms and signs involving the circulatory and respiratory systems

309

1.59

4.13

1.1

—

Fall on and from stairs and steps

147

2.18

4.13

1.1

—

Internal derangement of knee

205

1.98

4.13

1.2

1.1

—

Disorders of the thyroid gland

385

1.58

4.12

1.1

—

Hypokalaemia

2.99

4.11

1.3

1.1

—

Injuries to the thorax

285

1.82

4.11

1.1

—

Open wound of head

308

1.77

4.10

1.2

1.1

—

Diabetic retinopathy, excluding more controls

2.30

4.09

1.2

1.1

—

Extrapyramidal and movement disorders

229

1.92

4.08

1.2

1.1

—

Rheumatoid arthritis

147

2.11

4.08

1.1

1.2

—

Abdominal and pelvic pain

299

1.60

4.08

1.1

—

Crohn disease

2.71

4.08

1.1

—

Anaemia in chronic diseases classified elsewhere

8.06

4.06

1.1

1.3

—

Postprocedural disorders of nervous system

4.63

4.05

1.1

1.2

—

Chronic apical periodontitis

113

417

1.52

4.03

1.1

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

381

1.58

4.03

1.1

—

Brain glioblastoma, helper endpoint

10.11

4.02

1.3

—

Other joint disorders

280

1.62

4.01

1.1

—

Dementia in other diseases classified elsewhere

5.02

4.00

1.0

1.2

—

Diffuse large B-cell lymphoma

5.02

4.00

1.1

1.3

—

Diffuse large B-cell lymphoma, helper endpoint

5.02

4.00

1.1

1.3

—

Diffuse large B-cell lymphoma, including Hilmo

5.02

4.00

1.1

1.3

—

Malignant neoplasm of brain, including Hilmo

5.02

4.00

1.2

1.3

—

Pain in throat and chest

302

1.63

4.00

1.2

1.1

—

Abnormalities of breathing

309

1.61

4.00

1.2

1.1

—

Diseases of the respiratory system

163

1.81

3.99

1.2

1.1

—

Anxiety (asthma-related co-morbidities)

249

1.77

3.98

1.1

—

Disorder of external ear, unspecified

5.59

3.97

1.1

1.3

—

Triptan medication for migraine, min. 3 purchases

234

1.79

3.96

1.2

1.1

—

Bipolar affective disorders

2.60

3.96

1.1

—

Use of rivastigmine

2.66

3.96

1.1

1.2

—

Candidiasis, including avohilmo

163

2.09

3.96

1.1

—

Dermatitis

384

1.68

3.94

1.2

1.1

—

340

1.69

3.94

1.2

1.1

—

Any operation in hilmo

+∞

3.93

1.4

0.0

—

Liquid cancers, including Hilmo

191

1.94

3.92

1.2

—

Other obstetric conditions, not elsewhere classified

2.25

3.92

1.1

—

Pure hypercholesterolaemia

288

1.65

3.91

1.2

1.1

—

Inflammatory diseases of prostate (prostatitis)

2.72

3.91

1.2

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

216

1.92

3.89

1.1

—

Pain in thoracic spine

2.64

3.89

1.1

—

Explicit bacterial Sepsis

3.79

3.88

1.1

—

Papilloedema, unspecified

7.33

3.86

1.3

1.4

—

Other diseases of blood and blood-forming organs, wide

119

2.27

3.86

1.3

1.1

—

Sub-endpoint used in defining T1D endpoints

149

2.11

3.84

1.1

—

SLE, ICD10

6.03

3.82

1.1

1.3

—

SLE, strict definition

6.03

3.82

1.1

1.3

—

Decubitus ulcer and pressure area

4.30

3.81

1.0

1.2

—

Implicit fungal Sepsis, including avohilmo

4.30

3.81

1.1

—

Substance abuse

347

1.69

3.80

1.2

1.1

—

Other disorders of patella

2.53

3.79

1.2

1.1

—

Brain glioblastoma

8.84

3.78

1.3

—

Obstructive hydrocephalus

8.84

3.78

1.0

1.4

—

Monoplegia

8.84

3.78

1.7

1.4

—

Nystagmus and other irregular eye movements

8.84

3.78

1.3

1.4

—

Atypical virus infections of central nervous system, including avohilmo

12.17

3.77

1.2

1.4

—

Other/unspecified dorsalgia

198

1.95

3.76

1.1

—

Diseases of liver

187

1.98

3.76

1.2

1.1

—

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

2.22

3.71

1.1

—

Other anxiety disorders

206

1.86

3.71

1.2

1.1

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

2.44

3.69

1.0

1.1

—

Giant cell arteritis

5.02

3.69

1.2

—

Crohn's disease NAS

3.84

3.69

1.1

1.2

—

Hemiplegia

5.02

3.68

1.1

1.3

—

Neoplasms

240

1.64

3.66

1.1

—

Vocal cord dysfunction

3.63

3.66

1.2

1.1

—

Fungal Sepsis

5.65

3.66

1.0

1.1

—

Family history of certain disabilities and chronic diseases leading to disablement

5.64

3.66

1.1

—

Mental and behavioural disorders due to psychoactive substance use

353

1.66

3.65

1.2

1.1

—

Bacterial, viral and other infectious agents

3.12

3.64

1.0

1.1

—

Diseases of the skin and subcutaneous tissue

304

1.55

3.64

1.1

—

Sequelae of other and unspecified infectious and parasitic diseases

4.42

3.62

1.4

1.1

—

Dermatitis due to substances taken internally

4.42

3.62

1.3

1.2

—

Post-traumatic stress disorder

4.41

3.62

1.4

1.1

—

Reactive arthropathies, FINNGEN

4.01

3.59

1.0

1.2

—

Cerebral aneurysm, nonruptured

3.72

3.58

1.1

—

Disorders of skin appendages

297

1.74

3.57

1.2

1.1

—

Colonic or urogenital fistula

143

2.10

3.57

1.1

—

Other (seronegative) rheumatoid arthritis, wide

2.39

3.55

1.1

—

Exclusions for E4_PCOS_CONSORTIUM

267

1.64

3.54

1.1

—

Superficial injury of lower leg

137

2.12

3.53

1.1

—

Hypertensive diseases (excluding secondary)

148

1.85

3.53

1.1

—

Constipation

403

1.53

3.53

1.2

1.1

—

Benign neoplasm: Cerebral meninges

3.05

3.52

1.0

1.2

—

Erysipelas

257

1.74

3.52

1.1

—

Irritable bowel syndrome

144

2.09

3.51

1.2

1.1

—

Other specified/unspecified systemic involvement of connective tissue

4.25

3.50

1.1

1.3

—

Systemic lupus erythematosus, unspecified

6.19

3.50

1.1

1.3

—

Bronchitis

107

433

1.48

3.50

1.1

—

Abnormal involuntary movements

2.70

3.48

1.2

—

Soft tissue disorders

327

1.52

3.46

1.1

—

Deviated nasal septum

200

1.90

3.45

1.2

1.1

—

Acute generalized exanthematous pustulosis

4.56

3.43

1.3

1.2

—

Osteopathies and chondropathies

331

1.66

3.41

1.1

—

Volume depletion

2.98

3.41

1.1

—

Streptococcal septicaemia

3.52

3.39

1.2

—

Streptococcal septicaemia, including avohilmo

3.52

3.39

1.2

—

Mental and behavioural disorders due to alcohol

310

1.69

3.39

1.2

1.1

—

Tobacco use

4.09

3.39

1.5

1.2

—

Insulin, fast-acting (human)

2.66

3.39

1.2

1.1

—

Other Crohn's disease

3.76

3.38

1.0

1.2

—

Paraplegia, diplegia of upper limbs

7.05

3.37

1.3

—

Schizophrenia or delusion, excluding more controls

138

2.08

3.36

1.0

1.1

—

Complications of genitourinary prosthetic devices, implants and grafts

7.04

3.36

1.0

1.4

—

Striking against or struck by other objects

188

1.91

3.35

1.2

1.1

—

Other CVD

101

2.28

3.35

1.1

1.2

—

Acute renal failure

127

2.13

3.34

1.0

1.2

—

Sicca syndrome [Sjögren]

3.43

3.30

1.0

1.2

—

All anxiety disorders

270

1.67

3.30

1.1

—

All influenza (not pneumonia)

2.62

3.29

1.0

1.2

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

297

1.60

3.29

1.1

—

Triptan medication for migraine, single purchase ok

297

1.60

3.29

1.1

—

Use of levodopa decarboxylase inhibitor

2.54

3.29

1.1

1.2

—

Disorders of calcium metabolism

3.65

3.29

1.1

1.2

—

5-aminosalicylic acid

2.29

3.25

1.1

—

Reactive arthropathies

3.03

3.25

1.1

—

Other extrapyramidal and movement disorders in other diseases

122

2.13

3.25

1.2

1.1

—

Conjunctivitis (acute, non atopic)

155

1.99

3.24

1.1

—

Immunodeficiencies

4.18

3.19

1.3

—

Implicit fungal Sepsis

5.35

3.19

1.0

1.1

—

Bacterial, viral and other infectious agents, including avohilmo

2.86

3.19

1.0

1.1

—

Focal brain injury

6.37

3.18

1.0

—

Non-selective monoamine reuptake inhibitors

177

1.90

3.18

1.2

—

Gastro-oesophageal reflux disease

384

1.56

3.15

1.2

1.1

—

Lower back pain or/and sciatica

106

455

1.45

3.15

1.2

1.1

—

Alzheimer’s disease (Early onset), excluding more controls

8.10

3.14

1.2

1.0

—

Benign neoplasms

348

1.49

3.13

1.1

—

Enterocolitis due to Clostridium difficile

2.63

3.13

1.0

1.1

—

Allergic contact dermatitis

2.63

3.13

1.1

1.2

—

Polymyalgia rheumatica

2.54

3.12

1.1

1.2

—

Other blood glucose lowering drugs, excl. Insulins

2.54

3.12

1.4

1.1

—

Covid-19 suspected case

111

2.16

3.11

1.0

1.1

—

Generalized skin eruption due to drugs and medicaments

4.52

3.11

1.3

—

Invasive ventilation

3.44

3.10

1.1

1.2

—

Diseases of the ear and mastoid process

105

361

1.46

3.10

1.2

1.1

—

Other viral diseases, not elsewhere classified, including avohilmo

144

2.00

3.09

1.2

1.1

—

Myasthenia gravis

7.56

3.06

1.2

1.4

—

Vitreous haemorrhage

2.68

3.05

1.1

1.2

—

COPD (mode)

117

2.00

3.05

1.1

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

5.02

3.05

1.1

1.3

—

Injuries to the wrist and hand

100

457

1.45

3.05

1.1

—

Dislocation, sprain and strain of joints and ligaments of knee

331

1.61

3.05

1.2

1.1

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

274

1.63

3.02

1.1

1.2

—

Other disorders of nervous system

3.34

3.01

1.2

—

Other bacterial intestinal infections

2.30

3.00

1.1

1.2

—

Coxibs

2.08

2.99

1.2

1.1

—

Tuberculosis, IBD comorbidity

3.56

2.99

1.1

1.2

—

Tuberculosis, wide

3.56

2.99

1.1

1.2

—

Tuberculosis, wide, including avohilmo

3.56

2.99

1.1

1.2

—

Atypical virus infections of central nervous system

10.12

2.98

1.2

1.4

—

Encephalopathy

10.11

2.98

1.2

—

Benign intracranial hypertension

10.10

2.98

1.0

1.4

—

Congenital malformations of the nervous system

10.04

2.98

1.2

1.4

—

Familial hypercholesterolemia

2.35

2.98

1.3

1.2

—

Dermatitis and eczema

108

448

1.43

2.97

1.1

—

Other symptoms and signs involving the digestive system and abdomen

2.40

2.96

1.1

—

Acute and transient psychotic disorders

2.54

2.95

1.1

—

Diabetic nephropathy, excluding more controls

2.38

2.95

1.1

—

Panic disorder

2.54

2.95

1.1

—

Other intervertebral disc disorders

306

1.52

2.94

1.1

—

Wide developmental disorders, excluding more controls

9.78

2.93

1.0

1.2

—

Abnormal findings on examination of blood, without diagnosis

279

1.65

2.93

1.1

1.2

—

Sacroiliitis, not elsewhere classified

4.72

2.92

1.1

1.3

—

Diseases of tongue

4.71

2.91

1.1

1.2

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

6.13

2.91

1.0

1.1

—

Osteoporosis

136

1.96

2.89

1.1

—

Biological medication for rheuma

2.21

2.89

1.1

—

Any dementia

170

1.75

2.88

1.2

1.1

—

Cough

226

1.73

2.88

1.3

1.1

—

Unspecified dementia

2.85

2.88

1.2

—

Misadventures to patients during surgical and medical care

2.43

2.87

1.3

1.2

—

Candidiasis

2.43

2.87

1.1

1.2

—

Other and unspecified hydrocephalus

6.71

2.87

1.0

1.3

—

severe traumatic brain injury, does not include concussion

122

2.05

2.86

1.0

1.2

—

Erysipelas, including avohilmo

309

1.56

2.86

1.1

—

Dental operations

171

1.65

2.85

1.1

—

Asthma, unspecified (mode), excluding more controls

172

1.75

2.83

1.3

1.1

—

Asthma, excluding more controls

179

1.63

2.82

1.2

1.1

—

Other disorders of ear

378

1.47

2.82

1.1

—

Extracorporeal dialysis

3.34

2.81

1.1

1.2

—

Other/unspecified reactive arthropathies

3.34

2.81

1.0

1.2

—

Asthma (mode)

192

1.61

2.80

1.2

1.1

—

Mycoses, including avohilmo

474

1.45

2.79

1.1

—

Other sleep disorders

3.08

2.76

1.1

—

Other specified/unspecified necrotizing vasculopathies

8.40

2.75

1.2

1.3

—

Enthesopathies of lower limb, excluding foot

124

2.02

2.75

1.2

1.1

—

Polyuria

131

1.99

2.74

1.2

—

Immunodeficiency with predominantly antibody defects

5.03

2.73

1.4

—

Bacterial intestinal infections, IBD co-morbidities

2.20

2.73

1.1

1.2

—

Hypotension

2.20

2.72

1.1

1.2

—

Alcohol use disorder, ICD-based

255

1.69

2.72

1.2

1.1

—

Infections with a predominantly sexual mode of transmission

159

1.88

2.72

1.2

1.1

—

Spondylopathies

290

1.51

2.72

1.2

1.1

—

Dialysis, with operation codes

2.37

2.72

1.2

—

Subarachnoid haemorrhage

2.71

1.0

1.2

—

Inflammatory bowel disease

174

1.84

2.71

1.1

—

Asthma (only as main-diagnosis), excluding more controls

179

1.64

2.70

1.1

—

Patent foramen ovale

6.03

2.70

1.2

1.3

—

Autonomic disorders

6.03

2.70

1.3

1.5

—

Thyrotoxicosis, other and/or unspecified

2.15

2.70

1.2

1.1

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

160

1.88

2.69

1.1

—

Cardiac arrest

3.54

2.69

1.0

1.1

—

Elevated blood glucose level

3.01

2.69

1.0

1.2

—

Urticaria and erythema

211

1.75

2.69

1.2

1.1

—

Other enthesopathies

153

1.90

2.69

1.2

1.1

—

Benign neoplasm of brain and other parts of central nervous system

3.46

2.69

1.2

—

Hepatic failure, not elsewhere classified

4.23

2.68

1.4

1.2

—

Monoarthritis, not elsewhere classified

4.22

2.68

1.3

1.2

—

Obsessive-compulsive disorder

4.22

2.67

1.3

1.2

—

Tubulo-interstitial nephritis, not specified as acute or chronic

3.76

2.67

1.1

1.2

—

Asthma

191

1.59

2.67

1.2

1.1

—

Venous thromboembolism

329

1.58

2.65

1.1

—

Use of galantamine

3.15

2.64

1.0

1.2

—

Localized swelling, mass and lump of skin and subcutaneous tissue

183

1.80

2.64

1.3

1.1

—

Alzheimer’s disease (Late onset), excluding more controls

3.61

2.63

1.2

1.0

—

Nephropathy related operations

2.39

2.63

1.1

1.2

—

Other and unspecified visual disturbances

2.66

2.62

1.2

1.1

—

Other disorders of penis

2.65

2.61

1.1

—

Viral pneumonia

2.55

2.61

1.1

1.2

—

Dorsopathies

324

1.44

2.60

1.1

—

Tumor necrosis factor alpha inhibitors

2.25

2.60

1.1

—

Adrenocortical insufficiency

4.68

2.60

1.1

1.3

—

Asthma, unspecified (mode)

184

1.69

2.59

1.3

1.1

—

Fissure and fistula of anal and rectal regions

134

1.94

2.59

1.1

1.2

—

Unspecified haematuria

203

1.69

2.58

1.1

1.2

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

3.61

2.57

1.1

1.2

—

Benign neoplasm of other and unspecified endocrine glands

2.36

2.55

1.2

—

Other diseases of spinal cord

5.48

2.54

1.2

1.4

—

Other intracranial haemorrhages

5.47

2.54

1.2

1.3

—

Acute sinusitis

264

1.62

2.53

1.2

1.1

—

Fracture of rib(s), sternum and thoracic spine

193

1.76

2.53

1.0

1.2

—

Superficial injury of hip and thigh

2.22

2.53

1.1

—

Non-follicular lymphoma

2.61

2.53

1.1

1.2

—

Thyroiditis, ILD-related definition

2.60

2.53

1.2

—

Anogenital herpesviral [herpes simplex] infection, including avohilmo

2.60

2.53

1.2

1.1

—

Methotrexate

2.50

2.52

1.2

—

Disorders of lipoprotein metabolism and other lipidaemias

304

1.48

2.52

1.2

1.1

—

Other disorders of amniotic fluid and membranes

2.51

1.2

1.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

2.16

2.50

1.2

1.1

—

Early onset COPD

115

2.00

2.50

1.2

—

Inflammatory bowel disease, strict (require KELA)

129

1.94

2.49

1.1

—

Preparatory care for dialysis

3.47

2.48

1.2

—

Chronic sinusitis

239

1.67

2.48

1.2

1.1

—

Calculus of lower urinary tract

3.47

2.48

1.1

1.2

—

Crohn's disease of large intestine

3.47

2.48

1.1

1.2

—

Other and unspecified urticaria

2.11

2.48

1.3

1.1

—

Anogenital herpesviral [herpes simplex] infection

3.47

2.48

1.3

1.1

—

Other diseases of the digestive system

187

1.77

2.47

1.1

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.20

2.47

1.0

1.1

—

Non-Hodgkin lymphoma, all

3.82

2.46

1.3

1.2

—

Varicella [chickenpox]

3.82

2.46

1.1

—

Fracture of skull and facial bones

109

2.02

2.45

1.1

—

Parkinson's disease

2.24

2.43

1.1

1.2

—

Allergic asthma (mode), excluding more controls

2.24

2.43

1.0

1.1

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.13

2.43

1.0

1.2

—

Amyloidosis

5.03

2.40

1.2

1.3

—

Atopic dermatitis, strict definition with reimbursement

153

1.82

2.40

1.0

1.1

—

Impingement syndrome of shoulder

131

1.91

2.39

1.3

1.2

—

Diabetic maculopathy

2.29

2.39

1.1

—

Urolithiasis

182

1.76

2.38

1.1

1.2

—

Hypermobility syndrome

3.65

2.36

1.0

1.2

—

Hyperlipidaemia, other/unspecified

211

1.66

2.34

1.2

1.1

—

Migraine with aura and triptan purchases

2.15

2.34

1.1

—

Hypercalcemia

3.23

2.30

1.1

1.2

—

Other disorders of white blood cells

3.22

2.30

1.4

1.2

—

Parkinson's disease, including avohilmo

2.18

2.30

1.1

1.2

—

Other and unspecified nonorganic psychotic disorders

105

2.00

2.30

1.0

1.1

—

Other disorders of eyelid

260

1.60

2.29

1.2

1.1

—

Erosion and ectropion of cervix uteri

4.63

2.27

1.3

1.1

—

Parkinson's disease, strict definition

2.23

2.27

1.1

1.2

—

Spontaneous rupture of synovium and tendon

2.75

2.27

1.3

1.2

—

Ingrowing nail

3.49

2.27

1.3

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

358

1.41

2.27

1.1

—

Nail disorders

2.56

2.27

1.2

—

Varicella [chickenpox], including avohilmo

3.48

2.26

1.1

—

Diseases of oesophagus, stomach and duodenum

421

1.37

2.26

1.2

1.1

—

IBD patients in KELA-register

134

1.87

2.26

1.1

—

Other dialysis

3.91

2.25

1.1

1.2

—

Carpal tunnel syndrome

322

1.51

2.24

1.2

1.1

—

Fracture of lower leg, including ankle

319

1.54

2.24

1.1

—

Asthma (only as main-diagnosis)

191

1.55

2.24

1.1

—

Undefined dementia

2.45

2.23

1.2

—

Sequelae of injuries of head

3.11

2.22

1.0

1.2

—

Angina pectoris

262

0.53

2.22

1.2

1.1

—

Congenital malformations of cardiac septa

3.12

2.22

1.2

—

Urticaria

164

1.77

2.22

1.2

1.1

—

Benign neoplasm: Brain, supratentorial

5.59

2.21

1.0

1.3

—

Mixed connective tissue disease

5.59

2.21

1.0

1.4

—

Deficiency of other B group vitamins

5.58

2.21

1.0

1.3

—

Tuberculosis of other organs, strict

5.58

2.21

1.0

1.2

—

Tuberculosis of other organs, strict, including avohilmo

5.58

2.21

1.0

1.2

—

Other facial nerve disorders

5.57

2.21

1.0

1.3

—

Other/unspecified rheumatoid arthritis

2.34

2.21

1.1

—

Other (not insulin) diabetes medications

371

1.39

2.20

1.1

—

Disorders of conjunctiva

422

1.41

2.20

1.1

—

Congenital malformations of the circulatory system

2.19

2.18

1.1

—

Cutaneous abscess, furuncle and carbuncle

143

1.82

2.18

1.3

1.1

—

Disorders of sclera, cornea, iris and ciliary body

344

1.51

2.17

1.2

1.1

—

Rheumatism, unspecified

2.24

2.17

1.3

1.2

—

Septal defects

3.05

2.17

1.2

—

Vascular dementia

2.65

2.16

1.5

1.2

—

Hernia of abdominal wall, postoperative

2.39

2.16

1.1

—

Ectropion of eyelid

4.30

2.15

1.3

1.1

—

Other disorders of adrenal gland

3.69

2.15

1.1

1.3

—

Hyperfunction of pituitary gland

3.69

2.15

1.9

1.2

—

Diabetic neuropathy

2.23

2.15

1.1

—

Hypertension, essential

274

1.44

2.13

1.1

—

Crohn's disease of small intestine

2.78

2.13

1.0

1.2

—

Schizophrenia, schizotypal and delusional disorders

174

1.73

2.12

1.1

—

Allergic asthma (mode)

2.10

2.11

1.0

1.1

—

Iridocyclitis

116

1.90

2.10

1.2

—

Conjunctivitis

383

1.43

2.09

1.2

1.1

—

Crohn disease (strict definition, all UC cases excluded)

3.21

2.09

1.0

1.2

—

Infections with a predominantly sexual mode of transmission, including avohilmo

194

1.65

2.09

1.2

1.1

—

Other shoulder lesions

2.56

2.07

1.0

1.1

—

Pain associated with micturition

2.26

2.07

1.1

1.2

—

Retinoschisis and retinal cysts

5.02

2.07

1.0

1.2

—

Alcohol abuse, main dg, excluding more controls

2.26

2.07

1.0

1.1

—

Hidradenitis suppurativa

5.01

2.07

1.2

1.3

—

Crohn disease (strict definition, require KELA, min 2 HDR)

2.91

2.07

1.0

1.2

—

Diseases of oral cavity, salivary glands and jaws

175

1.53

2.06

1.1

1.2

—

Symptoms and signs concerning food and fluid intake

2.90

2.06

1.1

1.2

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

347

1.41

2.06

1.1

1.2

—

Noninfective enteritis and colitis

284

1.55

2.06

1.1

—

Superficial injury of head

124

1.85

2.05

1.2

1.1

—

Poisoning by medicine

117

1.88

2.05

1.0

1.1

—

Other bacterial intestinal infections, including avohilmo

117

1.88

2.05

1.1

—

Shoulder lesions

289

1.43

2.04

1.1

1.2

—

Chondrocostal junction syndrome [Tietze]

4.01

2.04

1.0

1.3

—

Generalized epilepsy

4.01

2.04

1.0

1.2

—

Benign neoplasm: Colon

335

1.48

2.03

1.2

—

KRA_PSY_EATING, excluding more controls

3.47

2.03

1.0

1.2

—

Other heart diseases, wide

364

1.38

2.01

1.1

—

Other diseases of upper respiratory tract

374

1.35

2.01

1.2

1.1

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

138

1.79

2.01

1.1

—

Biguanides

389

1.37

2.01

1.1

—

Intermittent heterotropia

3.08

2.01

1.1

1.2

—

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

3.08

2.01

1.1

1.2

—

Crohn disease (strict definition, require KELA)

2.82

2.00

1.0

1.2

—

Diabetes, insulin treatment (Kela reimbursement)

394

1.36

1.99

1.1

—

Benign neoplasm of colon, rectum, anus and anal canal

352

1.44

1.96

1.2

—

Other and unspecified disorders of white blood cells

3.34

1.96

1.3

1.2

—

Brain meningioma, including Hilmo

3.34

1.96

1.0

1.3

—

Convergent concomitant strabismus

3.34

1.96

1.0

1.2

—

Dyspnoea

439

1.36

1.95

1.2

1.1

—

Diabetic retinopathy

132

1.65

1.95

1.2

1.1

—

Amputation

2.36

1.94

1.1

1.2

—

Mumps

4.56

1.94

1.2

1.4

—

Mumps, including avohilmo

4.56

1.94

1.2

1.4

—

Sarcoidosis

2.19

1.94

1.3

1.1

—

Secondary uncertain malignant neoplasm

2.19

1.94

1.0

1.2

—

Other and unspecified injuries of shoulder and upper arm

3.76

1.93

1.2

1.3

—

Neuralgia and neuritis, unspecified

2.97

1.93

1.3

1.2

—

Complications of other internal prosthetic devices, implants and grafts

3.76

1.93

1.0

1.3

—

Other and unspecified mood [affective] disorders

2.97

1.93

1.0

1.2

—

Acute upper respiratory infections

420

1.34

1.92

1.2

1.1

—

Vascular dementia (undefined)

4.51

1.92

1.4

1.1

—

Tonsillectomy and adenotomy

210

1.52

1.92

1.0

1.1

—

Appendicitis, broad definition

429

1.40

1.91

1.1

—

Thyrotoxicosis

135

1.78

1.90

1.2

1.1

—

Obesity and other hyperalimentation

372

1.44

1.90

1.2

1.1

—

Chronic periodontitis, complicated

362

1.45

1.90

1.1

—

Other disorders of bone

1.92

1.89

1.1

1.2

—

Acute pancreatitis

1.92

1.89

1.3

1.1

—

GI-bleeding

188

1.65

1.89

1.1

—

Disorders of vitreous body and globe

313

1.48

1.88

1.1

1.2

—

Desensitization to allergens

3.19

1.88

1.4

1.2

—

Special screening examination for neoplasms

3.19

1.88

1.1

1.2

—

Spondylopathies (FG)

2.31

1.87

1.2

1.1

—

Use of hypnotics and sedatives

427

1.32

1.86

1.1

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

2.65

1.86

1.0

1.1

—

Other infectious diseases

2.65

1.86

1.3

1.2

—

Trigeminal neuralgia

2.86

1.86

1.0

1.1

—

Diseases of appendix

430

1.39

1.85

1.1

—

Type 2 diabetes, definitions combined, including avohilmo

353

1.36

1.85

1.1

—

Schizophrenia or delusion

174

1.67

1.85

1.0

1.1

—

DVT of lower extremities

100

1.90

1.85

1.2

—

101

387

1.32

1.84

1.2

1.1

—

Abnormal spermatozoa

2.21

1.84

1.2

—

Other noninflammatory disorders of cervix uteri

3.54

1.84

1.3

1.1

—

Diabetic nephropathy

1.90

1.83

1.1

—

Acute suppurative otitis media

134

1.74

1.83

1.2

1.1

—

Other strabismus

100

1.89

1.83

1.2

1.1

—

Other and unspecified dermatitis

334

1.47

1.82

1.2

1.1

—

Myositis

4.18

1.82

1.0

1.3

—

Alopecia areata

4.18

1.82

1.2

1.3

—

Degenerative diseases of the nervous system

163

1.59

1.82

1.2

1.1

—

Wide developmental disorders

4.16

1.81

1.0

1.2

—

Otitis externa, unspecified

2.12

1.81

1.1

—

Gout, strict definition

108

1.85

1.81

1.1

1.2

—

L04AD Calcineurin inhibitors

2.27

1.80

1.2

—

Other and unspecified injuries of head

2.57

1.80

1.1

—

Respiratory tuberculosis, confirmed and not-confirmed

3.05

1.80

1.0

1.2

—

Respiratory tuberculosis

3.05

1.80

1.0

1.2

—

Cardiac arrhythmias

191

1.51

1.79

1.1

—

Lymphoid leukaemia

2.76

1.79

1.3

—

Tuberculosis

2.76

1.79

1.0

1.2

—

Osteoporosis with pathological fracture (FG)

2.76

1.79

1.0

1.1

—

Other and unspecified effects of external causes

153

1.70

1.79

1.1

—

Acute appendicitis, no complications

334

1.46

1.77

1.1

—

Endometriosis of ovary

1.95

1.77

1.1

—

Fentanyl

2.34

1.76

1.0

1.2

—

Sequelae of injuries of neck and trunk

3.34

1.75

1.0

1.2

—

Hypogonadotropic hypogonadism

3.34

1.75

1.0

1.2

—

Optic neuritis

3.34

1.74

1.2

—

Radiculopathy

1.98

1.74

1.0

1.2

—

Obesity

372

1.42

1.74

1.2

1.1

—

Seropositive rheumatoid arthritis

109

1.83

1.74

1.1

1.2

—

Unspecified misadventure during surgical and medical care

2.67

1.72

1.3

1.2

—

Tongue abnormality

2.67

1.72

1.1

1.2

—

Disorders resulting from impaired renal tubular function

2.93

1.72

1.0

1.2

—

Residual foreign body in soft tissue

2.92

1.72

1.1

1.3

—

Use of donepezil

1.85

1.71

1.2

1.1

—

Obesity due to excess calories

282

1.49

1.70

1.2

1.1

—

Other peripheral vertigo

2.30

1.70

1.2

—

Non-invasive ventilation

1.93

1.70

1.4

1.1

—

Excessive attrition of teeth

377

1.42

1.70

1.1

—

Other cataract

196

1.52

1.69

1.2

—

Diseases of peritoneum

2.19

1.67

1.0

1.2

—

Special screening examination for other diseases and disorders

2.50

1.66

1.0

1.1

—

Alzheimer’s disease (Early onset)

3.16

1.66

1.2

—

Hypertension

279

1.37

1.65

1.1

—

2.10

1.65

1.2

1.1

—

Use of disulfiram, acamprosate or naltrexone

2.44

1.64

1.1

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

241

1.51

1.62

1.0

1.1

—

Exposure to other and unspecified animate mechanical forces

3.58

1.61

1.0

1.3

—

Other complications of surgical and medical care, not elsewhere classified

2.38

1.61

1.2

1.1

—

Disorders of vitreous body

311

1.44

1.60

1.1

1.2

—

Fracture of foot, except ankle

128

1.72

1.59

1.2

1.1

—

Hyperkalaemia

2.50

1.59

1.0

1.2

—

Hypertensive diseases

281

1.36

1.59

1.1

—

Nonsuppurative otitis media, including avohilmo

143

1.63

1.59

1.1

—

Lateral epicondylitis

2.07

1.59

1.1

—

Retinal detachments and breaks

214

1.54

1.58

1.2

1.1

—

conjunctival haemorrhage

2.33

1.58

1.0

1.2

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

1.83

1.58

1.1

—

Gingivitis and periodontal diseases

346

1.31

1.58

1.1

—

Sequelae of external causes of morbidity and mortality

136

1.69

1.58

1.1

—

Lesion of lateral popliteal nerve

2.70

1.58

1.3

1.2

—

Cluster headache, strict, including avohilmo

2.70

1.58

1.1

1.2

—

Atrial fibrillation and flutter with reimbursement

1.84

1.58

1.0

1.1

—

Cluster headache, wide,, including avohilmo

2.70

1.58

1.1

1.2

—

Endovascular or surgical operations to intracerebral aneurysms

2.70

1.58

1.0

1.2

—

Acne, including avohilmo

1.81

1.57

1.1

—

Benign neoplasm: Colon, unspecified

144

1.67

1.57

1.1

1.2

—

Sulfasalazine

144

1.67

1.57

1.1

—

Gout

136

1.64

1.56

1.1

1.2

—

Disorders of parathyroid gland

1.82

1.55

1.0

1.1

—

Unspecified/other endometriosis

2.28

1.55

1.1

—

Diseases of arteries, arterioles and capillaries

326

1.37

1.55

1.1

1.2

—

Left bundle-branch block

2.28

1.55

1.1

1.2

—

Ocular pain

2.28

1.55

1.3

1.2

—

Other infectious diseases, including avohilmo

2.28

1.55

1.3

1.2

—

Agranulocytosis

2.11

1.54

1.2

—

Hypertrophy of breast

1.88

1.54

1.1

—

Acute bronchitis

243

1.49

1.54

1.0

1.1

—

Other follicular disorders

2.43

1.53

1.4

1.2

—

Alcohol dependence

145

1.66

1.53

1.2

1.1

—

Deforming dorsopathies

145

1.66

1.53

1.1

—

Endometriosis ASRM stages 3,4

115

1.74

1.52

1.1

—

Chronic diseases of tonsils and adenoids

302

1.36

1.52

1.1

—

Disorders of tooth development and eruption

1.94

1.51

1.1

—

Chronic iridocyclitis

2.60

1.51

1.0

1.2

—

Combinations of oral blood glucose lowering drugs

169

1.60

1.51

1.3

1.2

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

373

1.30

1.51

1.1

—

Respiratory insufficiency

2.59

1.51

1.1

—

Separation of retinal layers (serosa)

2.86

1.50

1.3

1.2

—

Brain meningioma

2.86

1.50

1.0

1.3

—

Ptosis of eyelid

2.16

1.50

1.4

1.1

—

Type 2 diabetes, definitions combined

359

1.31

1.50

1.1

—

Acute pancreatitis (for exclusion)

108

1.76

1.50

1.3

1.2

—

Appendectomy

372

1.38

1.49

1.1

—

Spondyloarthritis

1.90

1.49

1.1

1.2

—

Poisoning by drugs, medicaments and biological substances

131

1.68

1.49

1.0

1.1

—

Inflammatory disease of uterus

2.00

1.48

1.2

1.1

—

Abnormal findings on diagnostic imaging of other body structures

2.00

1.48

1.1

—

Calculus of kidney and ureter

170

1.59

1.48

1.1

1.2

—

Other and unspecified psoriasis

2.44

1.48

1.1

1.2

—

Exposure to other and unspecified inanimate mechanical forces

2.44

1.47

1.0

1.2

—

Neuromuscular dysfunction of bladder

2.44

1.47

1.0

1.1

—

Spondylosis

259

1.42

1.47

1.1

1.2

—

Gout, unspecified

124

1.70

1.46

1.1

1.2

—

Foreign body entering into or through eye or natural orifice

2.37

1.45

1.1

1.2

—

Follow-up examination after treatment for malignant neoplasms

2.37

1.45

1.0

1.2

—

Type 2 diabetes, strict (exclude DM1)

361

1.31

1.45

1.1

—

Undetermined asthma, excluding more controls

2.37

1.45

1.4

1.1

—

Caught, crushed, jammed or pinched in or between objects

2.50

1.45

1.0

1.2

—

Hypertrophy of breast in women and men

102

1.77

1.44

1.1

—

Diverticular disease of intestine

285

1.35

1.44

1.1

—

Spinal instabilities

3.13

1.44

1.0

1.3

—

Chronic hepatitis, not elsewhere classified

3.13

1.44

1.2

—

Acetic acid derivatives and related substances

1.70

1.43

1.1

—

Diseases of the digestive system

283

1.44

1.43

1.1

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1.81

1.43

1.1

—

Clear cell adenocarcinoma of kidney

2.73

1.43

1.2

—

Contact with other sharp object(s)

2.31

1.43

1.2

—

Other respiratory disorders and diseases

110

1.73

1.42

1.2

—

Other diseases of the respiratory system

110

1.73

1.42

1.2

—

Other noninflammatory disorders of uterus, except cervix

1.76

1.41

1.3

1.1

—

Anterior Iridocyclitis

103

1.75

1.40

1.1

—

Excessive vomiting in pregnancy

2.25

1.40

1.4

1.1

—

Fenamates

1.95

1.39

1.4

1.1

—

Abnormal findings on antenatal screening of mother

2.42

1.39

1.1

1.2

—

Social phobias

2.41

1.39

1.3

1.2

—

Postpartum care and examination

1.95

1.38

1.1

—

Seropositive rheumatoid arthritis, strict definition

1.94

1.38

1.1

—

Irregular menses

190

1.46

1.37

1.2

1.1

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

2.20

1.37

1.0

1.1

—

Other symptoms and signs involving the circulatory and respiratory systems

2.20

1.37

1.3

1.1

—

Other diseases of intestine

1.80

1.37

1.2

—

Fibromyalgia

2.20

1.37

1.3

1.2

—

Gestational diabetes (for exclusion)

118

1.57

1.36

1.1

—

Other endocrine disorders

2.62

1.36

1.3

1.2

—

Embolic stroke

2.94

1.36

1.0

1.2

—

Diseases of inner ear

349

1.37

1.35

1.1

—

Substance use, excluding alcohol

112

1.70

1.35

1.1

—

Atopic dermatitis, strict definition

155

1.58

1.35

1.0

1.1

—

Acute appendicitis

418

1.33

1.35

1.1

—

Unspecified mental disorder

232

1.47

1.33

1.0

1.1

—

Achilles tendinitis

2.04

1.32

1.4

1.2

—

Infective dermatitis

2.04

1.32

1.0

1.2

—

FESS (DNB20)

1.97

1.32

1.4

1.1

—

Superficial injury of shoulder and upper arm

1.97

1.32

1.2

1.1

—

Congenital malformations, deformations and chromosomal abnormalities

331

1.37

1.32

1.2

1.1

—

Personality disorders, excluding more controls

105

1.71

1.31

1.1

—

Functional dyspepsia

168

1.55

1.31

1.0

1.1

—

Coagulation defects, purpura and other haemorrhagic conditions

1.74

1.30

1.1

—

Diseases of middle ear and mastoid

285

1.38

1.30

1.1

—

Autoimmune hepatitis, wide definition

2.50

1.30

1.3

1.2

—

Sequelae of other external causes

2.50

1.30

1.0

1.3

—

Undetermined asthma

2.09

1.30

1.4

1.1

—

Endometriosis

105

1.55

1.30

1.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

1.84

1.29

1.1

1.2

—

Other inflammatory liver diseases

2.36

1.29

1.3

1.1

—

Thrombocytopenia, unspecified

2.36

1.29

1.0

1.2

—

Hypermetropia

2.35

1.29

1.3

1.2

—

Spinal stenosis

226

1.40

1.29

1.2

—

Acne vulgaris

2.35

1.29

1.1

1.2

—

Chronic conjunctivitis

2.78

1.28

1.8

1.3

—

Other specified/unspecified soft tissue disorders

2.78

1.28

1.2

1.3

—

Somatoform disorder

1.89

1.28

1.1

—

Gout, idiopatic and unspecified

153

1.57

1.28

1.1

1.2

—

Familial hypercholesterolemia, with ischemic heart disease

2.09

1.27

1.5

1.2

—

Burns and corrosions of external body surface, specified by site

2.00

1.27

1.2

—

Ulcerative colitis (strict definition, require KELA)

1.79

1.26

1.2

—

Use of memantine

123

1.57

1.25

1.1

—

Use of other anti-dementia drugs

123

1.57

1.25

1.1

—

Sulfonylureas

160

1.49

1.24

1.1

1.2

—

Glucosamine medication

227

1.41

1.24

1.1

1.2

—

Benign neoplasm of urinary organs

2.40

1.24

1.0

1.2

—

Erosion of teeth , including avohilmo

158

0.51

1.24

1.0

1.1

—

Disorders of vestibular function (Vertigo)

295

1.39

1.24

1.1

—

Restless leg syndrome

1.86

1.23

1.3

1.1

—

Benign lipomatous neoplasm of other sites/unspecified

2.00

1.23

1.3

1.2

—

Atrial fibrillation and flutter

1.63

1.22

1.0

1.1

—

Bitten or struck by other mammals

1.91

1.22

1.0

1.2

—

Soft tissue disorders related to use, overuse and pressure

147

1.57

1.22

1.1

1.2

—

Statin medication

226

1.35

1.22

1.1

—

Polyhydramnios

2.64

1.21

1.4

1.1

—

Non-small cell lung cancer, squamous, helper endpoint

2.64

1.21

1.2

—

Diseases of pulp and periapical tissues, including avohilmo

371

1.25

1.21

1.2

1.1

—

Diabetes mellitus in pregnancy

1.61

1.21

1.2

1.1

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.72

1.21

1.2

1.1

—

Other neurotic disorders

2.31

1.18

1.0

1.2

—

Foreign body in alimentary tract

2.31

1.18

1.2

—

Infectious mononucleosis, including avohilmo

2.11

1.18

1.0

1.1

—

Infectious mononucleosis

2.11

1.18

1.0

1.1

—

Supervision of normal pregnancy

0.43

1.18

1.0

1.1

—

Gout, FINNGEN

172

1.50

1.17

1.1

1.2

—

Asthma and allergy, excluding more controls

2.08

1.16

1.0

1.1

—

Chalazion

2.00

1.16

1.4

1.1

—

Malignant neoplasm of breast, HER-positive

128

1.51

1.15

1.0

1.2

—

Other specified/unspecified dorsopathies

2.50

1.15

1.0

1.3

—

Malignant neoplasm of breast, ER-positive, including Hilmo

128

1.51

1.15

1.0

1.2

—

Erectile dysfunction

2.05

1.15

1.3

1.2

—

Non-small cell lung cancer, squamous

2.50

1.15

1.2

—

Secondary and unspecified malignant neoplasm of lymph nodes

2.05

1.15

1.0

1.2

—

Viral and other specified intestinal infections, including avohilmo

136

1.56

1.15

1.1

—

Ulcerative colitis, NAS

1.81

1.15

1.2

—

Purpura and other haemorrhagic conditions

1.81

1.14

1.0

1.1

—

Coxarthrosis [arthrosis of hip](FG)

216

1.37

1.14

1.1

1.2

—

Chronic gastritis

158

1.52

1.14

1.1

—

Ethmoidectomy

1.85

1.13

1.4

1.1

—

Congenital malformations of heart and great arteries

1.85

1.13

1.2

1.1

—

Hyperkinetic disorders, excluding more controls

2.02

1.12

1.0

1.2

—

Cirrhosis of liver, NAS

2.34

1.12

1.0

1.2

—

Suppurative and necrotic conditions of lower respiratory tract

2.34

1.12

1.0

1.2

—

Eustachian salpingitis and obstruction

2.00

1.12

1.0

1.2

—

Allergic urticaria

2.00

1.12

1.0

1.2

—

Unspecified privation

1.90

1.12

1.1

1.2

—

Other superficial mycoses, including avohilmo

1.90

1.12

1.2

—

Acute alcohol intoxication

143

1.54

1.11

1.1

—

Burns and corrosions

1.78

1.10

1.2

—

Heart failure and antihypertensive medication

1.62

1.10

1.0

1.1

—

Viral pneumonia (unknown virus, not influenza)

2.26

1.10

1.1

1.2

—

Ischemic heart diseases

333

1.27

1.10

1.1

—

Other diseases of liver

1.67

1.10

1.1

—

Disorders of refraction and accommodation

143

1.53

1.09

1.2

1.1

—

Right bundle-branch block

2.38

1.09

1.4

1.2

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

2.38

1.09

1.2

1.3

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

2.38

1.09

1.0

1.2

—

Other diseases of peritoneum

2.38

1.09

1.0

1.3

—

Psychotic depression

2.38

1.09

1.0

1.1

—

Myocardial infarction, without ST-elevation

234

1.39

1.08

1.1

1.2

—

Malignant neoplasm of kidney, except renal pelvis

1.95

1.08

1.1

1.2

—

Presbycusis

1.87

1.08

1.0

1.1

—

Other diseases of pleura

255

1.36

1.08

1.2

—

Acute peritonitis

2.19

1.08

1.0

1.2

—

Malignant neoplasm, including Hilmo

332

1.26

1.07

1.1

—

Malignant neoplasm, wide definition

332

1.26

1.07

1.1

—

Nonsuppurative otitis media

104

1.59

1.06

1.1

—

Unspecified kidney failure

1.92

1.06

1.3

1.2

—

Other and unspecified nerve root and plexus disorders, also in other diseases

105

1.62

1.05

1.0

1.1

—

Vulvovaginal ulceration/inflammation in other diseases

2.12

1.05

1.1

1.2

—

Retinal detachment with retinal break

1.79

1.04

1.3

1.2

—

Diseases of pulp and periapical tissues and dental caries

207

1.31

1.04

1.2

1.1

—

Superficial injury of abdomen, lower back and pelvis

1.67

1.03

1.0

1.1

—

Other and unspecified abdominal hernia

2.28

1.03

1.0

1.3

—

Systemic atrophies primarily affecting the central nervous system

2.28

1.03

1.4

1.2

—

Abnormal findings on examination of urine, without diagnosis

2.28

1.03

1.2

—

Recurrent dislocation of patella

2.28

1.03

1.4

1.1

—

L01XX Other antineoplastic agents

2.06

1.03

1.6

1.2

—

Etanercept

2.06

1.03

1.0

1.2

—

Solid cancers

321

1.26

1.02

1.1

—

Dermatophytosis

1.73

1.02

1.1

1.2

—

Glomerulonephritis

1.92

1.02

1.1

1.2

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

310

1.33

1.01

1.2

1.1

—

Other/unspecified synovitis and tenosynovitis

1.89

1.01

1.5

1.2

—

Conduction disorders

163

1.43

1.01

1.1

1.2

—

Conjunctivitis (acute, non atopic), including avohilmo

424

1.22

1.00

1.1

—

Phobic anxiety disorders

1.88

1.00

1.2

1.1

—

Disorders of muscles

1.88

1.00

1.0

1.2

—

Keratitis

205

1.42

1.00

1.2

1.1

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

180

1.45

1.00

1.3

1.2

—

Glucagon-like peptide-1 (GLP-1) analogues

180

1.45

1.00

1.3

1.2

—

Fracture of neck

2.00

1.00

1.0

1.2

—

Mental and behavioural disorders due to sedatives or hypnotics

2.00

1.00

1.1

1.2

—

Seborrhoeic keratosis

139

1.51

0.99

1.1

—

Otitis externa

123

1.55

0.99

1.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

172

1.45

0.99

1.2

1.1

—

Atopic dermatitis

279

1.31

0.98

1.2

1.1

—

Dialysis

2.18

0.98

1.0

1.2

—

Toxic effect of contact with venomous animals

2.18

0.98

1.0

1.3

—

Pyothorax

2.18

0.98

1.0

1.2

—

Episcleritis

2.18

0.98

1.2

1.3

—

Maltreatment syndromes

2.18

0.98

1.4

1.1

—

Mandibular retrognathia

0.00

0.97

0.0

1.2

—

Disorders of synovium and tendon

276

1.32

0.97

1.2

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

210

0.67

0.97

1.1

—

Coxarthrosis

192

1.34

0.97

1.2

—

Corneal ulcer

1.63

0.97

1.3

1.2

—

Car occupant injured in other and unspecified transport accidents

1.63

0.97

1.1

—

Dental caries, including avohilmo

232

1.28

0.96

1.1

—

Effects of foreign body entering through natural orifice

132

1.52

0.96

1.1

—

Olecranon bursitis

0.00

0.96

0.0

1.2

—

Other disorders of kidney and ureter

1.74

0.96

1.2

1.1

—

Noninfectious colitis NAS

1.74

0.96

1.0

1.1

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

116

1.55

0.96

1.3

1.2

—

Peripheral artery operations in Hilmo

1.74

0.96

1.1

1.2

—

Basal cell carcinoma

186

1.36

0.96

1.2

—

Any event in cancer register

344

1.24

0.96

1.1

1.2

—

Injury of muscle and tendon at shoulder and upper arm level

216

1.39

0.95

1.2

1.1

—

Seborrhoeic dermatitis

1.77

0.94

1.2

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1.65

0.94

1.1

1.2

—

Chondropathies

1.65

0.94

1.1

—

Benign neoplasm: Caecum

1.78

0.94

1.1

—

Other/unspecified enthesopathies of lower limb, excluding foot

1.89

0.94

1.1

1.2

—

Injury of unspecified body region

1.89

0.94

1.1

1.2

—

Temporomandibular joint disorders, including avohilmo

251

1.35

0.93

1.1

—

Tinnitus

125

1.52

0.93

1.1

—

Other acquired deformities of musculoskeletal system and connective tissue

2.23

0.93

1.0

1.2

—

Other noninfective gastroenteritis and colitis

125

1.52

0.93

1.0

1.1

—

Disorders of breast

243

1.34

0.93

1.1

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.73

0.92

1.2

—

Malignant neoplasm of urinary organs, including Hilmo

1.82

0.92

1.1

1.2

—

Failed induction of labour

2.15

0.91

1.3

1.1

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS